BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27984555)

  • 1. Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience.
    Ford D; Muzambi M; Nkhata MJ; Abongomera G; Joseph S; Ndlovu M; Mabugu T; Grundy C; Chan AK; Cataldo F; Kityo C; Seeley J; Katabira E; Gilks CF; Reid A; Hakim J; Gibb DM;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):508-516. PubMed ID: 27984555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
    Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
    Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
    Nkhata MJ; Muzambi M; Ford D; Chan AK; Abongomera G; Namata H; Mambule I; South A; Revill P; Grundy C; Mabugu T; Chiwaula L; Hakim J; Kityo C; Reid A; Katabira E; Sodhi S; Gilks CF; Gibb DM; Seeley J; Cataldo F;
    BMC Health Serv Res; 2016 Nov; 16(1):660. PubMed ID: 27852291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
    Tenthani L; Haas AD; Tweya H; Jahn A; van Oosterhout JJ; Chimbwandira F; Chirwa Z; Ng'ambi W; Bakali A; Phiri S; Myer L; Valeri F; Zwahlen M; Wandeler G; Keiser O
    AIDS; 2014 Feb; 28(4):589-598. PubMed ID: 24468999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention.
    Abrams EJ; Langwenya N; Gachuhi A; Zerbe A; Nuwagaba-Biribonwoha H; Mthethwa-Hleta S; Sahabo R; Lesosky M; Okello V; Myer L
    AIDS; 2019 Jan; 33(1):45-54. PubMed ID: 30289804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial.
    Joseph J; Gotora T; Erlwanger AS; Mushavi A; Zizhou S; Masuka N; Boeke CE; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S190-S197. PubMed ID: 28498189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
    Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
    PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
    Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
    BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on 'Option B+' in rural Zimbabwe.
    Dzangare J; Takarinda KC; Harries AD; Tayler-Smith K; Mhangara M; Apollo TM; Mushavi A; Chimwaza A; Sithole N; Magure T; Mpofu A; Dube F; Mugurungi O
    Trop Med Int Health; 2016 Feb; 21(2):202-9. PubMed ID: 26555353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
    Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
    Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe.
    Chan AK; Ford D; Namata H; Muzambi M; Nkhata MJ; Abongomera G; Mambule I; South A; Revill P; Grundy C; Mabugu T; Chiwaula L; Cataldo F; Hakim J; Seeley J; Kityo C; Reid A; Katabira E; Sodhi S; Gilks CF; Gibb DM;
    BMC Health Serv Res; 2014 Aug; 14():352. PubMed ID: 25138583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(8):148-51. PubMed ID: 23446514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Program Implementation of Option B+ at a President's Emergency Plan for AIDS Relief-Supported HIV Clinic Improves Clinical Indicators But Not Retention in Care in Mbarara, Uganda.
    Miller K; Muyindike W; Matthews LT; Kanyesigye M; Siedner MJ
    AIDS Patient Care STDS; 2017 Aug; 31(8):335-341. PubMed ID: 28650703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early retention among pregnant women on 'Option B + ' in urban and rural Zimbabwe.
    Chimwaza AN; Tweya H; Mugurungi O; Mushavi A; Mukungunugwa S; Sithole N; Nyakura J; Senkoro M; Owiti P; Ncube R; Tapera T; Mandewo W; Edwards JK; Mangombe A; Taramusi I
    AIDS Res Ther; 2021 Apr; 18(1):10. PubMed ID: 33794957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.